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SOCS3 Is Essential in the Regulation
of Fetal Liver Erythropoiesis
about day 10 and involves a dramatic expansion of ery-
throid lineage cells in the fetal liver. This expansion is
highly dependent upon Epo, the Epo receptor, and
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A second group of gene products are involved in regulat-Aikawamachi 2432-3, Kurume 839-0861
ing the numbers of red cells, and their deletion resultsJapan
in anemias or erythrocytosis. As noted above, this group
includes Epo, the receptor for Epo, and the Epo recep-
tor±associated kinase JAK2. Similarly, mutations of
Summary stem cell factor (SCF) and its receptor c-Kit are associ-
ated with anemia (Galli et al., 1994), and while an interac-
SOCS3 (CIS3/JAB2) is an SH2-containing protein that tion between c-Kit and EpoR (Wu et al., 1995a) may be
binds to the activation loop of Janus kinases, inhibiting responsible, other possibilities, independent of EpoR,
kinase activity, and thereby suppressing cytokine sig- also exist.
naling. During embryonic development, SOCS3 is Mice deficient in BclXL die embryonically due to a
highly expressed in erythroid lineage cells and is Epo severe anemia associated with increased apoptosis of
independent. Transgene-mediated expression blocks erythroid cells (Motoyama et al., 1995). Curiously, em-
fetal erythropoiesis, resulting in embryonic lethality. bryos deficient in DNA ligase I also die at 12±15 days
SOCS3 deletion results in an embryonic lethality at with a profound anemia (Bentley et al., 1996), suggesting
12±16 days associated with marked erythrocytosis. that this enzyme may be important in protecting cells
Moreover, the in vitro proliferative capacity of progeni- from the apoptotic pathways or that the high replicative
tors is greatly increased. SOCS3-deficient fetal liver rate of the cells cannot be supported without the en-
stem cells can reconstitute hematopoiesis in lethally zyme. Consistent with a role for apoptosis in regulating
irradiated adults, indicating that its absence does not red cell production, mice deficient in either FADD (Yeh
disturb bone marrow erythropoiesis. Reconstitution of et al., 1998) or Caspase 8 (Hakem et al., 1998) exhibit
lymphoid lineages in JAK3-deficient mice also occurs an accumulation of erythroid cells. These examples
normally. The results demonstrate that SOCS3 is criti- serve to emphasize the possibility that a number of fac-
cal in negatively regulating fetal liver hematopoiesis. tors contribute both positively and negatively to the
rapid expansion of erythroid cells that occurs in the fetal
liver at 10±15 days of embryonic development.
Introduction Erythropoiesis may also be negatively regulated
through the interaction of proteins with the Epo receptor
The appropriate regulation of erythropoiesis is essential complex. It has been proposed that the tyrosine phos-
for both embryonic development and adult red cell pro- phatase SHP-1 can interact with the Epo receptor and
downregulate JAK2 activity (Klingmuller et al., 1995).duction. At least three distinct stages of erythropoiesis
More recently, the CIS gene was identified as an Epo-characterize embryonic development. Erythropoiesis
induced immediate early gene (Yoshimura et al., 1995;first occurs within the blood islands of the embryo begin-
Matsumoto et al., 1997). The CIS protein binds the tyro-ning at approximately day 7. This stage is characterized
sine phosphorylated Epo receptor through its SH2 do-by the production of nucleated red cells expressing the
main and when overexpressed in transiently transfectedembryonic pattern of globins and is not dependent upon
cells can block Epo signaling. However, CIS-deficienterythropoietin (Epo), the major cytokine regulating sub-
mice are phenotypically normal in all regards (unpub-sequent stages of erythropoiesis (Wu et al., 1995b). Nor
lished data).does this stage of erythropoiesis require JAK2, a kinase
Following the discovery of CIS, a number of relatedthat is required for the function of a number of cytokines,
proteins were identified and given multiple names, in-including Epo (Neubauer et al., 1998; Parganas et al.,
cluding JAB (JAK binding), SOCS (suppressor of cyto-1998). The second stage of erythropoiesis begins at
kine signaling), and SSI (Stat induced Stat inhibitor). The
family is characterized by an SH2 domain and a carboxy-
terminal, unique conserved motif referred to as the#To whom correspondence should be addressed (e-mail: jamesihle@
stjude.org). SOCS box. SOCS1 and SOCS3 share the ability to bind
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directly to the activation loop phosphotyrosine of the deficient embryos, demonstrating the critical role of Epo
JAKs and thereby block their catalytic activity (Sasaki signaling in its expression (P). However BclXL is ob-
et al., 1999; Yasukawa et al., 1999). Mice deficient in served in Stat5a/b-deficient embryos (O) at levels com-
SOCS1 die perinatally with a complex pathology (Naka parable to the levels seen in wild-type embryos (N).
et al., 1998; Starr et al., 1998). However, our recent stud- Therefore, unlike BclXL, which requires Epo receptor
ies (Marine et al., 1999 [this issue of Cell]) demonstrate signaling but not Stat5a/b function, SOCS3 expression
that this lethality is due to altered lymphocyte function is independent of Epo regulation.
and have suggested that SOCS1 may be essential for The developmental specificity of expression was as-
blocking cytokine signaling at specific stages of lympho- sessed by examining erythroid progenitors in the blood
cyte development. islands of 9.5-day-old embryos. As illustrated (Figure
A potential role for SOCS3 has been less obvious. 1H), Ter119-positive cells in the blood islands did not
SOCS3 expression is transiently induced in a variety of express SOCS3. Similarly, no SOCS3 expression was
situations, and overexpression studies have frequently observed in the Ter119-positive cells, predominantly
been used to propose a functional role for this expres- enucleated mature red cells from the liver sinuses of
sion. In particular, roles in growth hormone function 15.5-day-old embryos (J). Therefore, SOCS3 is primarily
(Adams et al., 1998), lymphocyte proliferation (Cohney expressed during the stage of fetal liver erythropoiesis
et al., 1999), leptin (Bjorkbaek et al., 1998), CNTF (Bjor- that is characterized by the dramatic expansion of the
baek et al., 1999), IL-11 (Aurernhammer and Melmed, early erythroid lineage cells, and, although variable in
1999), and IL-10 signaling (Ito et al., 1999) have been pro- individual cells, this expression is independent of Epo
posed. In the studies presented here, we use transgenic receptor signaling.
and gene disruption approaches to provide evidence
that SOCS3 is a critical negative regulator of fetal liver
Enforced Expression of SOCS3 In Vivo Specificallyerythropoiesis.
Suppresses Fetal Liver Erythropoiesis
Since SOCS3 was predominantly expressed in erythroidResults
populations, we determined the consequences of con-
stitutive expression resulting from an H2K, MHC classSOCS3 Is Expressed in Erythroid Progenitors
I promoter-containing transgene construct (Figure 2).in the Fetal Liver
This promoter, in combination with a Moloney long ter-SOCS3 is expressed at low levels in adult tissues (Starr
minal repeat promoter, has been shown to drive expres-et al., 1997) and induced by a number of cytokines (Ad-
sion of a transgene in virtually all stages of hematopoie-ams et al., 1998; Auernhammer et al., 1998; Bjorbaek et
sis including stem cells (Kondo et al., 1997). Embryos ofal., 1998; Song and Shuai, 1998; Bjorbaek et al., 1999).
4±12 cells were injected with the H2K-SOCS3 construct,However, by in situ hybridization of E12.5 embryos,
and the progeny were initially examined for founders.SOCS3 was highly expressed in the fetal liver as well
Since no founders were obtained, recipient femalesas other ill-defined sites (Figure 1B). In contrast, SOCS1
were sacrificed at 12.5 days and the embryos examined.was expressed at low levels (C), while CIS was ex-
As illustrated in Figure 2, embryos were observed thatpressed at detectable levels in the fetal liver and other
had no evidence of fetal liver erythropoiesis (3 and 4) insites (D). The relevance of CIS expression is unknown,
addition to the normal appearing embryos (1 and 2). Thissince CIS-deficient mice have no detectable phenotype
phenotype is strikingly similar to that seen in embryos(unpublished data).
deficient in either JAK2 (Parganas et al., 1998) or the EpoTo further assess SOCS3 protein expression, sections
receptor (Wu et al., 1995b), both of which are associatedof fetal livers from 12.5-day-old embryos were examined
by immunofluorescence. To identify the erythroid pro- with embryonic lethality.
genitors and lineage committed cells, the sections were To establish that the lack of fetal liver erythropoiesis
also exposed to an antibody against Ter119 directly was associated with the transgene, the embryos were
conjugated with phycoerythrin. Ter119 is expressed on genotyped by PCR. As illustrated in Figure 2 (lower
all erythroid lineage committed cells (Ikuta et al., 1990) panel), the two normally appearing embryos did not
that require Epo for survival and differentiation (Wu et contain the transgene, while both embryos that lacked
al., 1995b). As illustrated (Figures 1E, 1F, and 1I), SOCS3 detectable fetal liver erythropoiesis contained the trans-
was highly expressed in Ter119-positive fetal liver cells gene. Among a total of 46 embryos, 38 embryos did not
at day 12.5. SOCS3 was not expressed in the Ter119- contain the transgene and were phenotypically normal.
negative hepatocytes within the fetal liver. The specific- Among the 8 embryos containing transgenic sequences,
ity of detection is indicated by the absence of SOCS3 2 were phenotypically normal, while the remainder lacked
expression in Ter119-positive fetal liver cells from a detectable fetal liver erythropoiesis. Since it would be
SOCS3-deficient embryo (G). However, there was a anticipated that not all the hematopoietic stem cells
great variation in the levels of SOCS3 expression in would be transduced, the results suggest that the high-
individual Ter119-positive fetal liver cells. The variable level, constitutive expression of SOCS3 can suppress
levels of expression suggested that expression is regu- erythropoiesis.
lated. To assess the role of Epo signaling, SOCS3 ex-
pression was examined in Ter119-positive fetal liver
Deletion of SOCS3 Causes Embryonic Lethalitycells from Epo receptor- (M), Stat5a/b- (L), or JAK2-
Associated with Erythrocytosisdeficient mice (K). As illustrated, SOCS3 expression was
To disrupt the SOCS3 gene, a targeting vector was con-observed in all cases. As a control we also examined
structed (Figure 3A) that would delete the exon con-BclXL expression. In contrast to SOCS3, BclXL expres-
sion is not seen in Ter119-positive cells in Epo receptor± taining the entire coding region of the gene and thus
SOCS3 Regulates Embryonic Erythropoiesis
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Figure 1. In Situ Hybridization and Immunofluorescence to Detect SOCS3 Expression in Embryonic Erythroid Progenitors
(A) Bright field image of wild-type, day 12.5 embryo saggital section. Wild-type E12.5 sections hybridized with cRNA probes for SOCS3 (B),
SOCS1 (C), and CIS (D). SOCS3 protein expression ([E]; green) in Ter1191 erythroid progenitors ([F]; red) in wild-type E12.5 fetal liver sinusoid.
(I) SOCS3/Ter119 overlay in wild-type E12.5 fetal liver sinusoid. Ter1191 cells at stages E9.5 (H) and E15.5 (J) do not express SOCS3 protein.
Ter1191 cells from SOCS32/2 E12.5 (G) are negative for SOCS3 protein, whereas similar cells from Stat5ab2/2 (L), JAK22/2 (K) and EpoR2/2
(M) E12.5 fetal livers retain expression of SOCS3 protein. BclXL expression, used here as a control, is very high in E12.5 wild-type embryos
(N) and Stat5a/b- (O) deficient fetal liver Ter119-positive cells, whereas similar cells from an Epo receptor±deficient embryo lacked expres-
sion (P).
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Figure 2. Ectopic Expression of SOCS3 In
Vivo Alters Fetal Liver Erythropoiesis
The full-length SOCS3 cDNA was cloned in
the pSP65-H2K-I-LTR vector to generate the
transgenic construct illustrated here. Recipi-
ent foster females were sacrificed at day 12.5
of gestation, and the embryos were exam-
ined. Integration of the DNA transgenic con-
struct was assessed by PCR using primers
PH2K and PRev. The quality of the genomic DNA
template isolated from each embryo was con-
firmed using primers PFor and PRev (lower
panel). The transgene-positive embryos (3
and 4) are characterized by the visually obvi-
ous absence of red cells in the fetal liver and
surrounding tissues when compared to wild-
type littermates (embryos 1 and 2).
create a completely protein null mutation. Three inde- increased with age such that after day 14, all the SOCS3-
deficient embryos that had survived display erythro-pendently derived targeted ES clones gave rise to mu-
tant strains, all of which had identical phenotypes. Het- cytosis. Lastly, all the SOCS3-deficient embryos are
smaller than heterozygous or wild-type embryos at theerozygous mice were phenotypically normal and were
bred to obtain mice homozygous for the disrupted allele. same age. The delayed development may be secondary
to the erythrocytosis.As illustrated in Figure 1G, SOCS3 protein is not detect-
able in the homozygously deficient embryos. Typing of One consequence of the extensive erythrocytosis in
the embryos might be a shift from the more immaturethe progeny failed to detect homozygous individuals,
with one exception, indicating that deletion of the gene populations to the more mature, nonproliferative popu-
lations of cells. As illustrated in Figure 4A, such an effectresulted in an embryonic lethality. In the one exception,
the pup was born runted and died within 24 hr. To estab- was observed in colony assays. The numbers of the most
differentiated erythroid colony-forming cells (CFU-E)lish the period of lethality, embryos were taken at various
stages of development and typed. As illustrated in Table and the lesser differentiated burst-forming cells (BFU-E)
were reduced approximately 10-fold as were the number1, approximately the expected numbers of homozygous
embryos were present at 10±12 days, but the percentage of multilineage progenitors that formed colonies in the
presence of IL-3. However, there was a marked differ-of homozygous individuals decreased with age.
ence in the proliferative capacity of the early, IL-3 re-The only obvious pathology associated with the ho-
sponsive cells. As illustrated in Figure 4B, the sizes ofmozygously deleted embryos was a marked erythro-
the IL-3/Epo-induced BFU-E and CFU-Mix coloniescytosis (Figures 3C and 3E). This was most striking in
from fetal liver cells of SOCS3-deficient embryos werethe abdominal region and surrounding the fetal liver. In
typically 5±10 times larger than the colonies derivedaddition, the structure of the fetal liver was completely
from fetal liver cells from wild-type embryos.distorted by the abundance of erythroid cells, particu-
larly in older embryos (data not shown). Erythemia was
also evident throughout the embryo, often including the SOCS3 Deficiency Does Not Significantly Affect
head and even the lens of the eye. Histological examina- Adult Hematopoiesis
tion revealed extensive erythrocytosis in the fetal liver To explore the potential role of SOCS3 in adult hemato-
and in other thoracic organs. For example, at 12.5 days poiesis, fetal liver cells from SOCS3-deficient embryos
the ventricles and aortic loop normally contain relatively were used to reconstitute lethally irradiated wild-type
few erythroid cells; however, both are filled with red adult mice (Figure 5). Mice were analyzed at 2 months
cells in SOCS3-deficient embryos (compare Figures 3B following reconstitution with fetal liver cells. As illus-
and 3C). In normal embryos at day 15.5, the majority of trated in Figure 5A, PCR analysis of FACS-sorted
the erythrocytes in the fetal liver are enucleated, major Thy1.2-, B220-, or Mac1-positive blood cells demon-
red cells (Figure 4D), whereas in SOCS3-deficient em- strated the predominance of cells derived from the
bryos a significant fraction of the cells are still nucleated SOCS3-deficient fetal liver cells (2/2) and from hetero-
(Figure 4E). As indicated in Table 1, the frequency of zygous fetal liver cells (1/2). In each of the mice recon-
stituted with fetal liver cells from homozygously deletedmarked erythrocytosis in the SOCS3-deficient embryos
SOCS3 Regulates Embryonic Erythropoiesis
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Figure 3. Targeted Disruption of the SOCS3 Gene Results in a Phenotype of Erythrocytosis
(A) Structure of the SOCS3 locus, SOCS3-neo targeting vector, and predicted SOCS3 mutated locus is shown.
(B) The morphology of an E12.5 wild-type embryo; the presence of cells of erythroid origin in various organs of the embryo was visualized
by immunofluorescence using a Ter119 antibody.
(C) An E12.5 SOCS3-deficient embryo. The mutant embryo shows sign of severe erythrocytosis; Ter119-positive cells were ectopically detected
in large numbers and in many different organs including the venticule of the heart (as shown here).
(D) The morphology of an E15.5 wild-type embryo; the histological appearance of its liver is also illustrated. At that stage of development,
the majority of the erythroid cells are fully mature enucleated red blood cells.
(E) An E15.5 SOCS3-deficient embryo. The structure of the liver is completely altered; this organ is full of red blood cells. As opposed to the
littermate controls, the vast majority of those cells are still nucleated.
embryos, the wild-type allele was only evident in the 5B. PCR analysis of the bone marrow cells from mice
reconstituted with fetal liver cells from SOCS3 homozy-Thy1.2-positive population and was estimated to consti-
tute at most 20% of the T cells. As illustrated in (A), gously deficient embryos (2/2) detected the presence
of only the mutant allele. As indicated, there were nothere were no significant differences in the number of
peripheral red cells or white blood cells in any of the detectable differences in the number of IL-7-dependent
colonies between animals reconstituted with fetal liverreconstituted animals.
The ability of bone marrow from reconstituted mice cells from heterozygous or homozygous SOCS3-defi-
cient embryos. However, there was a consistent andto form hematopoietic colonies is illustrated in Figure
Cell
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Table 1. Genotypic Distribution of Newborn Mice and Embryos from SOCS3 Heterozygous Intercrosses
Fetal Liver
Stage No. of Litters Total No. 1/1 1/2 2/2 Erythrocytosis (%) 2/2 (%)
10.5 1 10 3 4 3 0 30
11.5 5 42 13 20 9 33 21
12±12.5 30 211 76 102 33 50 16
13±13.5 14 83 24 49 10 66 12
14.5 5 30 11 16 3 100 10
15.5 6 30 10 18 2 100 7
16.5 5 31 11 19 1 100 3
F2 36 193 70 122 1 ,1
Postnatal mice and embryos were genotyped by PCR, as shown in Figure 3B. The embryos were collected between day 10.5 and 16.5 of
pregnancy from SOCS31/2 females crossed to SOCS31/2 males. Histological examination of some mutant embryos revealed extensive
erythrocytosis in the fetal liver (as shown in Figure 4); the frequency at which this phenotype was observed is indicated in the table in percent
of the total number of embryos analyzed.
significant increase of approximately 2-fold in the num- that results in pathology. However, the cells have an
enhanced responsiveness to cytokines.ber of CFU-E, BFU-E, and CFU-Mix. As observed with
To evaluate the potential role of SOCS3 in thethe colonies from fetal liver (above), the bone marrow±
lymphoid lineages, fetal liver cells from SOCS3-deficientderived colonies were significantly larger in size (data not
embryos were used to reconstitute sublethally irradiatedshown). The results demonstrate that SOCS3-deficient he-
JAK3-deficient mice. Approximately 2 months followingmatopoietic progenitors can functionally reconstitute le-
reconstitution, thymus and spleen were examined forthally irradiated animals without excessive proliferation
evidence of reconstitution of the lymphoid populations
by FACS analysis. As illustrated in Figure 6A, fetal liver
cells from SOCS3-deficient embryos reconstituted the
T cell population in the thymus comparable to fetal liver
cells from heterozygous embryos. Similarly, the B cell
population in the spleen was reconstituted comparably
to that seen in mice reconstituted with bone marrow
from control mice. Moreover, splenic lymphocytes from
mice reconstituted with SOCS3-deficient fetal liver cells
were capable of responding to increasing concentra-
tions of IL-2 in the presence of limiting concentrations
of anti-CD3 as well as responding to anti-IgM in the
presence of increasing concentrations of IL-4 (Figure
6C). The data demonstrate that SOCS3 deficiency does
not result in any overt alterations in T or B cell differentia-
tion or function, although it will be important to study
these cells in more detail for subtle effects in subset
differentiation or function.
Discussion
The results demonstrate that SOCS3 plays a critical role
in fetal liver erythropoiesis at a stage when it is highly
expressed in erythroid lineage cells. The pathology seen
in the absence of SOCS3 is a dramatic expansion of
erythropoiesis within the fetal liver as well as throughout
the embryo. Morphologically, the abnormal expansion
that occurs within the fetal liver causes, in later stage
embryos, a complete loss of the normal architecture of
the liver (data not shown). However, the most visuallyFigure 4. In Vitro Proliferative Capacity of Early Hematopoietic Pro-
striking phenotype is the greatly expanded numbers ofgenitors in Liver Cells from SOCS3 Wild-Type and Mutant Embryos
red cells and red cell precursors throughout the embryo.(A) In vitro colony-forming ability of fetal liver hematopoietic progeni-
It is possible that the increased numbers of red celltors from SOCS3-deficient and wild-type embryos. The mean and
standard deviation of the number of colonies/105 cells are shown progenitors are a direct consequence of the increased
from the assays with four 12.5-day-old embryos of each genotype. production within the fetal liver. However, it is also possi-
The four SOCS3 embryos chosen showed signs of erythrocytosis. ble that in the absence of SOCS3 peripheral sites are
(B) Typical appearance of CFU-Mix (top panel) and BFU-E (lower
able to produce erythrocytes. Another possibility is thatpanel) colonies derived from wild-type (left) and SOCS3-deficient
erythroid progenitors that migrate out of the fetal liverembryos (right) after 18 days of incubation in methylcellulose media
retain a proliferative capacity that would normally becontaining optimal concentrations of appropriate recombinant
growth factors. controlled through the induction of SOCS3 expression.
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Figure 5. SOCS3 Does Not Play a Major,
Nonredundant Role during Adult Hemato-
poiesis
Fetal liver cells from SOCS3 heterozygous
and homozygous mutant embryos were used
to reconstitute lethally irradiated wild-type
adult mice. (A) summarizes the analysis of
peripheral blood from such mice, performed
2 months following reconstitution. To assess
the contribution of cells from SOCS3-defi-
cient fetal liver cells, a PCR reaction was used
to detect the presence of the altered allele in
FACS-sorted Thy1.2-, B220-, or Mac1-posi-
tive cells. DNA isolated from two SOCS3 het-
erozygous mice were used as controls (1/2
cont.). The peripheral red blood count (RBC)
and white blood count (WBC) of such recon-
stituted animals are indicated in the lower
part of (A). PCR analysis of bone marrow cells
from reconstituted mice with SOCS31/2 or
SOCS32/2 fetal liver cells is illustrated in (B).
A comparison in the numbers of bone mar-
row±derived CFU-E, BFU-E, CFU-Mix (IL-3),
and IL-7-dependent colonies between ani-
mals reconstituted with fetal liver cells from
heterozygous or homozygous SOCS3-defi-
cient embryos is also shown in (B).
The phenotype raises a general question regarding apoptotic cells and hematopoietic failure. In contrast to
SOCS3, BclXL levels are regulated through Epo signal-the mechanisms by which the amount of erythropoiesis
is regulated within the fetal liver. The availability of Epo ing. Recently, a potential role for Stat5a/b in BclXL regu-
lation during fetal liver erythropoiesis was proposedis clearly a critical factor, and ultimately it is the availabil-
ity of Epo that must define the limiting level of erythropoi- based on (1) the presence of Stat-binding sites in the
gene, (2) their functionality in expression constructs inesis. However, it is becoming obvious that the disruption
of several genes can result in a significant, and patholog- cell lines, and (3) the partial inhibition of BclXL transcripts
in a long-term cell line by overexpression of Stat5a domi-ical, expansion of red cells, suggesting that Epo does
not define the amount of erythropoiesis during the pe- nant-negative protein (Socolovsky et al., 1999). How-
ever, the expression of BclXL in Stat5a/b-deficient orriod of fetal liver production. In particular, the embryos
deficient in either FADD (Yeh et al., 1998) or Caspase 8 control fetal liver cells was not examined. As assessed
by immunofluorescence in our studies (Figure 1O),(Varfolomeev et al., 1998) exhibit an erythrocytosis that
is very similar to that observed in SOCS3-deficient em- Stat5a/b-deficient cells express BclXL at levels compa-
rable to wild-type cells. Therefore, we conclude thatbryos. This observation has suggested the possibility
that a TNF-like receptor system may exist that controls the Stat5 proteins are not absolutely required for BclXL
expression in fetal erythroid cells.the numbers of erythroid lineage cells through induction
of apoptosis. Such a mechanism could be envisioned The mechanism by which SOCS3 negatively influ-
ences fetal liver erythropoiesis is hypothesized to beto simply regulate the extent of erythropoiesis, or it could
also contribute to defining the sites at which erythropoi- through its ability to inhibit JAK2, which, based on the
phenotype of JAK2-deficient embryos (Parganas et al.,esis can occur.
A role for apoptosis is also supported by the critical 1998), is critical for Epo receptor function and erythro-
poiesis. The SH2 domain of SOCS1 has been shown torole that BclXL plays in fetal liver hematopoiesis (Moto-
yama et al., 1995). In particular, deletion of BclXL results bind to the activation loop tyrosine of JAKs and to inhibit
their kinase activity (Yasukawa et al., 1999), and we havein an embryonic lethality due to a dramatic increase in
Cell
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Perhaps the most important, unanswered question
deals with the factors that control SOCS3 expression
during erythropoiesis. This is particularly critical, since,
as demonstrated with transgenic embryos, overexpres-
sion can completely block erythropoiesis. A number of
studies have identified cytokines that can induce SOCS3
RNA, including CNTF (Bjorbaek et al., 1999), leptin (Bjor-
baek et al., 1998), LIF (Auernhammer et al., 1998, 1999),
IL-11 (Auernhammer and Melmed, 1999), IL-10 (Ito et
al., 1999), and growth hormone (Adams et al., 1998).
Thus, the concept has emerged that SOCS proteins are
feedback inhibitors of cytokine signaling. However, in
none of these situations has the level of protein been
examined relative to the levels that are required for inhi-
bition of JAK function. This is particularly important,
since, in our experience, the SOCS proteins turn over
very rapidly in many of the cell types in which they are
induced. Irrespective, the expression of SOCS3 in fetal
liver cells does not require Epo receptor signaling. Two
possibilities exist: namely that SOCS3 expression is de-
velopmentally regulated in a manner which is indepen-
dent of cellular signaling or, alternatively, that another
signaling pathway is involved. One intriguing signaling
possibility is that stem cell factor, acting through c-Kit,
suppresses a developmentally programmed expression
of SOCS3.
The possibility that SOCS3 expression is developmen-
tally regulated is also of considerable interest. In particu-
lar, it could be envisioned that it is the activation of
SOCS3 expression at later stages of erythropoiesis that
is responsible for turning off Epo signaling and promot-
ing the cells into the terminal stages of differentiation.
This possibility is consistent with the phenotype of the
Figure 6. Reconstitution of the Lymphoid Lineages of JAK3-Defi-
SOCS3-deficient mice; particularly the predominancecient Mice by Fetal Liver Cells from SOCS3-Deficient Embryos
of more immature cells in peripheral sites. It is also
(A) JAK3-deficient mice were sublethally irradiated and reconstitu-
consistent with the increased colony size as indicatedted by injection of liver cells from wild-type embryos or SOCS3-
below. In this regard it should also be noted that SOCS1deficient embryos. Five weeks after reconstitution, the ability to
reconstitute the thymocyte and the splenic populations was exam- expression in thymocytes is most likely to be develop-
ined by analysis of the expression of the T lineage markers CD4 mentally regulated and, specifically, is not regulated by
and CD8, and the expression of the B lineage markers B220 and cytokines (Marine et al., 1999). Moreover, the phenotype
IgM, respectively. The thymus and the spleen of a JAK32/2 animal of SOCS1-deficient mice strongly supports the concept
were included in this experiment as a control.
that the critical role for SOCS1 is in thymocyte differenti-(B) To assess the contribution of cells from SOCS3-deficient fetal
ation (Marine et al., 1999). Therefore, the developmentalliver cells, a PCR reaction was used to detect the presence of the
regulation of SOCS protein expression may be morealtered allele in FACS-sorted Thy1.2-positive cells.
(C) The functional capabilities of splenic lymphocytes were exam- biologically relevant than the observation that cytokines
ined by assessing their ability to proliferate to a limiting concentra- can transiently induce their expression.
tion of anti-CD3 in the presence of increasing concentrations of IL-2 Associated with the overt erythrocytosis was a de-
(left), or to a limiting concentration of anti-IgM in the presence of crease in the number of CFU-E and BFU-E in colony
increasing concentrations of IL-4 (right). The samples shown include
assays with fetal liver cells from SOCS3-deficient mice.cells from JAK3-deficient mice (filled triangles) and JAK3-deficient
This was not anticipated based on the observation thatmice reconstituted with fetal liver cells from heterozygous or homo-
there were many more nucleated cells present at variouszygous SOCS3-deficient embryos (filled circles and filled rectangles,
respectively). sites in SOCS3-deficient embryos. However, there is
also an increased amount of apoptosis, and we would
propose that in these embryos Epo becomes limiting
recently found that SOCS3 similarly binds the activation and a significant fraction of the cells undergo apoptosis
loop kinase of JAK2 and inhibits activity (Sasaki et al., prior to terminal differentiation. Remarkably, a decrease
1999). In addition to inhibiting JAK kinase activity, it is in colony-forming cells was also observed in Caspase
also possible that SOCS proteins, through interaction 8±deficient embryos that have a virtually identical pa-
of the SOCS box with the elongin BC complex (Kamura thology of erythrocytosis (Varfolomeev et al., 1998). In
et al., 1998; Zhang et al., 1999), may target the kinases contrast to the decrease in colony numbers, the num-
for degradation. All these experiments, however, have bers of cells produced in the colonies are greatly in-
relied on overexpression studies. It will therefore be creased. This could be due to a decreased cell cycle
important to use mice genetically deficient in SOCS3 as time or to the ability of the cells to undergo more rounds
well as cytokine signaling to establish the specificity of of proliferation. We favor the later possibility, although
additional studies will be needed to substantiate thisSOCS3 inhibition.
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described (van Deursen et al., 1993). Seven independent ES clonesmodel. Irrespective, it is possible that SOCS3 expres-
were injected, of which three gave germline transmission.sion is turned on with differentiation, and it is this induc-
tion that limits the colony size of the wild-type progeni-
Genotyping of SOCS3-Deficient Mice by Southern Blottors. However, it should be emphasized that terminal
and PCRdifferentiation does occur in colonies from SOCS3-defi-
Genotyping of mice was performed by Southern blot analysis atcient fetal liver cells, demonstrating that SOCS3 expres- first, then using a PCR-based assay. For this assay, approximately
sion modifies the program rather than being an essential 200 ng of mouse tail DNA or genomic DNA isolated from mouse
component for terminal differentiation. embryos was amplified per 25 ml reaction using 2.0 U of Qiagen
Taq-polymerase in a final concentration of each dNTP at 0.2 mM,As demonstrated through the reconstitution experi-
MgCl2 at 1.5 mM. The PCR primers consisted of P1 primerments, a deficiency of SOCS3 has very little effect on
(59-AGGGGAAGAGACTGTCTGGGG), P2 (59-CCGCACAGCGGCCGerythropoiesis in the adult animal and specifically was
CTACC), and the neomycin primer P3 (59-ACCACACTGCTCGAnot associated with an obvious erythrocytosis or other CATTGGGT) as shown in Figure 3A. The PCR cycle profile was as
pathology. However, there was an increase in CFU-E follows: 1 cycle at 948C for 4 min followed by 35 cycles at 948C for
and BFU-E in bone marrow progenitors, and the prolifer- 1 min, 628C for 30 s, 728C for 1 min; and finally 1 cycle at 728C for
5 min. A 200 bp fragment indicates the presence of the wild-typeative capacity of individual progenitors, based on colony
allele, whereas a 300 bp fragment is amplified from the mutatedsize, was increased comparable to that seen in the fetal
allele.liver. The absence of erythrocytosis likely reflects a dif-
ference in the control of erythropoiesis in the adult ani-
Generation and Analysis of SOCS3 Transgenic Micemal. In particular, the amount of adult erythropoiesis
We created the H2K-SOCS3 transgenic construct by introducingmay be more dependent upon the availability of Epo.
SOCS3 full-length cDNA into the NotI cloning site of the previously
This would suggest that mice reconstituted with SOCS3- described pSP65-H2K-I-LTR vector (Domen et al., 1998). Purified
deficient bone marrow would be much more responsive DNA of the construct was microinjected into zygotes and trans-
or sensitive to exogenous administered EpoÐa possibil- planted into oviduct of pseudopregnant foster mothers. Successful
integration of the injected DNA was monitored using a PCR-basedity that we are examining.
appoach. Since no founders were obtained, recipient females wereReconstitution experiments in JAK3-deficient animals
sacrificed at day 12.5 of gestation and the embryos examined. Prim-were done to examine the possible role of SOCS3 in
ers PFor (59-TCCACGCTGGCTCCGTGCG) and PRev (59-GCTCCTTAAAlymphoid development. This experiment was prompted GTGGAGCATCA) were used to detect endogenous SOCS3; primer
by our recent studies (Marine et al., 1999) with SOCS1 PH2K, chosen in the H2K promoter portion of the transgenic construct
as well a recent study that suggested that SOCS3 might (59-TCACTTCTGCACCTAACCTGG), and primer PRev were used for
the detection of the SOCS3 transgene (see Figure 2). The PCR cyclebe involved in suppressing Stat5 tyrosine phosphoryla-
profile was as follows: 1 cycle at 948C for 4 min followed by 35tion and thereby block lymphocyte proliferation (Cohney
cycles at 948C for 1 min, 628C for 30 s, 728C for 2 min; and finallyet al., 1999). Deficiency of SOCS1 is associated with a
1 cycle at 728C for 5 min.
perinatal lethality (Naka et al., 1998; Starr et al., 1998).
A lymphoid defect for this lethality is indicated by its
Colony Assayselimination by introducing a RAG2 deficiency and by the
Fetal liver cells were prepared from livers of E11.5±E12.5 embryos
ability to transfer the pathology with lymphoid lineage and bone marrow cells from femurs of wild-type lethally irradiated
reconstitution (Marine et al., 1999). These results sug- mice reconstituted with either wild-type or SOCS3 mutant fetal liver
gest that the high levels of SOCS1 expression in the cells. The cells were plated and the colonies scored exactly as
previously described (Parganas et al., 1998; Teglund et al., 1998).thymus play a role in lymphocyte development. This
observation emphasizes that while SOCS1 and SOCS3
may function identically in binding JAK kinases and in- Histology/In Situ Hybridization and Immunofluorescence
Embryos taken at day 12.5 of pregnancy from wild-type, JAK22/2,hibiting their activity, the specificity of biological func-
Stat5ab2/2, and EpoR2/2 mice were fixed in 10% buffered formalintion is likely to be related to their unique sites of high
for 24 hr, and 6 mm sections were prepared from frozen tissuelevels of expression.
samples. Day 9.5, 12.5, and 15.5 embryos were fixed in 10% buffered
formalin, parafin embedded, and sectioned at 4 mm. Slides prepared
Experimental Procedures for histological analysis were stained with hematoxylin and eosin
as described previously. RNA in situ hybridization was carried out on
Construction of SOCS3 Targeting Vector frozen cryosections essentially as described (Angerer and Angerer,
The SOCS3 gene was isolated from a 129/SVE mouse genomic 1992) using [a-33P]-UTP-labeled antisense cRNA probes transcribed
library in lEMBL3 using SOCS3 full-length cDNA probe. Positive from plasmids containing murine cDNA fragments of CIS (216 bp),
clones were restriction mapped and partially sequenced. For the SOCS1 (200 bp), and SOCS3 (300 bp). Immunofluorescence was
targeting construct, a 13 kb SalI/HindIII fragment was subcloned, carried out using a PE-conjugated anti-mouse TER119 antibody to
followed by replacement of a 3 kb NotI/XbaI fragment containing detect numbers of erythroid progenitors in all embryonic sections.
the entire SOCS3 coding region with a neomycin resistance cassette SOCS3 protein levels were detected using a rabbit polyclonal anti-
previously described (van Deursen et al., 1991). A herpes simplex sera anti-SOCS3 N-terminal peptide antibody (aa 5±21 of mouse
thymidine kinase (HSV-tk) cassette mediating negative selection SOCS3) and Alexa488-anti-rabbit polyclonal antibody (Molecular
was inserted in the 39-end of the SOCS3-neo construct. Probes) as a secondary antibody. Briefly, tissue sections were re-
fixed for 20 min in 10% buffered formalin, blocked for 1 hr in a
solution of 10% BSA in 13 PBS followed by incubation overnightTransfection of ES Cells and Generation
of SOCS3-Deficient Mice at 48C with a 1:100 dilution of primary anti-SOCS3 antibody. Slides
were washed with 13 PBS and incubated for a further 2 hr at roomE14 (129/Ola mouse strain) ES cells were cultured as described
(Parganas et al., 1998). Twenty-five micrograms of SalI linearized temperature with a 1:100 dilution of PE-anti TER119 and Alexa488-
anti-rabbit antibodies. Slides were washed three times with 13 PBSSOCS3 plasmid construct was electroporated into the ES cells and
grown under double selection as described (Parganas et al., 1998). and mounted under coverslips using Antifade-Fluoromount (Fisher).
Ter119-positive cells and SOCS3 expression levels were visualizedConditions for blastocyst injection of correctly targeted and karyo-
typically normal ES clones and breeding to generate mice homozy- by confocal microscopy using a Leica DM-IRBE microscope to-
gether with Leica TCS-NT software.gous for the mutated SOCS3 gene were performed essentially as
Cell
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Reconstitution Domen, J., Gandy, K.L., and Weissman, I.L. (1998). Systemic overex-
pression of BCL-2 in the hematopoietic system protects transgenicFetal liver cells from wild-type or SOCS3-deficient embryos were
used to reconstitute sublethally irradiated JAK3-deficient mice (900 mice from the consequences of lethal irradiation. Blood 91, 2272±
2282.Rads) as well as wild-type lethally irradiated mice (1200 Rads). Ap-
proximately 3 3 106 liver cells in 500 ml of PBS containing 2% of Galli, S.J., Zsebo, K.M., and Geissler, E.N. (1994). The kit ligand,
fetal bovine serum were injected into the tail blood vessel of the stem cell factor. Adv. Immunol. 55, 1±96.
recipient animals. Hakem, R., Hakem, A., Duncan, G.S., Henderson, J.T., Woo, M.,
Soengas, M.S., Elia, A., Pompa, J.L., Kagi, D., Khoo, W., et al. (1998).
Flow Cytometry and Proliferation Responses Differential requirement for caspase 9 in apoptotic pathways in vivo.
These assays were performed exactly as previously described (Par- Cell 94, 339±352.
ganas et al., 1998). Ikuta, K., Kina, T., MacNeil, I., Uchida, N., Peault, B., Chien, Y.-H., and
Weissman, I.L. (1990). A developmental switch in thymic lymphocyte
maturation potential occurs at the level of hematopoietic stem cells.Histology
For sectioning, tissues were fixed in 10% phophate-buffered forma- Cell 62, 863±874.
lin (Fisher), parafin embedded, sectioned, and stained in hematoxy- Ito, S., Ansari, P., Sakatsume, M., Dickensheets, H., Vazquez, N.,
lin and eosin. Donnelly, R.P., Larner, A.C., and Finbloom, D.S. (1999). Interleukin-
10 inhibits expression of both interferon alpha- and interferon
gamma-induced genes by suppressing tyrosine phosphorylation ofAcknowledgments
STAT1. Blood 93, 1456±1463.
We would like to thank Irv Weismann (Stanford) for providing the Kamura, T., Sato, S., Haque, D., Liu, L., Kaelin, W.G.J., Conaway,
pSP65-H2K-I-LTR vector for the transgenic studies. The authors R.C., and Conaway, J.W. (1998). The Elongin BC complex interacts
would also like to thank Suzette Wingo for her excellent technical with the conserved SOCS-box motif present in members of the
assistance. The ES cell line used in these studies was kindly pro- SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev.
vided by Jan van Deursen. This work is supported by the Cancer 12, 3872±3881.
Center CORE grant CA21765, by the grant RO1 DK42932 to J. N. I., Klingmuller, U., Lorenz, U., Cantley, L.C., Neel, B.G., and Lodish, H.F.
by grant PO1 HL53749, and by the American Lebanese Syrian Asso- (1995). Specific recruitment of the hematopoietic protein tyrosine
ciated Charities (ALSAC). phosphatase SH-PTP1 to the erythropoietin receptor causes inacti-
vation of JAK2 and termination of proliferative signals. Cell 80,
729±738.Received July 21, 1999; revised August 10, 1999.
Kondo, M., Akashi, K., Domen, J., Sugamura, K., and Weissman,
I.L. (1997). Bcl-2 rescues T lymphopoiesis, but not B or NK cellReferences
development, in common gamma chain-deficient mice. Immunity 7,
155±162.Adams, T.E., Hansen, J.A., Starr, R., Nicola, N.A., Hilton, D.J., and
Billestrup, N. (1998). Growth hormone preferentially induces the Marine, J.-C., Topham, D.J., McKay, C., Wang, D., Parganas, E.,
rapid, transient expression of SOCS3, a novel inhibitor of cytokine Stravopodis, D., Yoshimura, A., and Ihle, J.N. (1999). SOCS1 defi-
receptor signaling. J. Biol. Chem. 273, 1285±1287. ciency causes a lymphocyte-dependent perinatal lethality. Cell 98,
this issue, 609±616.Andrews, N.C., and Orkin, S.H. (1994). Transcriptional control of
erythropoiesis. Curr. Opin. Hematol. 1, 119±124. Matsumoto, A., Masuhara, M., Mitsui, K., Yokouchi, M., Ohtsubo, M.,
Misawa, H., Miyajima, A., and Yoshimura, A. (1997). CIS, a cytokineAngerer, L.M., and Angerer, R.C. (1991). Localization of mRNAs by
inducible SH2 protein, is a target of the jak-stat5 pathway and modu-in situ hybridization. Methods Cell Biol. 35, 37±71.
lates stat5 activation. Blood 89, 3148±3154.Auernhammer, C.J., and Melmed, S. (1999). Interleukin-11 stimulates
Motoyama, N., Wang, F., Roth, K.A., Sawa, H., Nakayama, K., Naka-proopiomelanocortin gene expression and adrenocorticotropin se-
yama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., and Loh, D.Y.cretion in corticotroph cells: evidence for a redundant cytokine net-
(1995). Massive cell death of immature hematopoietic cells and neu-work in the hypothalamo-pituitary-adrenal axis. Endocrinology 140,
rons in Bcl-x-deficient mice. Science 267, 1506±1510.1559±1566.
Naka, T., Matsumoto, T., Narazaki, M., Fujimoto, M., Morita, Y.,Auernhammer, C.J., Chesnokova, V., Bousquet, C., and Melmed, S.
Ohsawa, Y., Saito, H., Nagasawa, T., Uchiyama, Y., and Kishimoto,(1998). Pituitary corticotroph SOCS3: novel intracellular regulation
T. (1998). Accelerated apoptosis of lymphocytes by augmented in-of leukemia-inhibitory factor-mediated proopiomelanocortin gene
duction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficientexpression and adrenocorticotropin secretion. Mol. Endocrinol. 12,
mice. Proc. Natl. Acad. Sci. USA 95, 15577±15582.954±961.
Neubauer, H., Cumano, A., Muller, M., Wu, H., Huffstadt, U., andAuernhammer, C.J., Bousquet, C., and Melmed, S. (1999). Autoregu-
Pfeffer, K. (1998). Jak2 deficiency defines an essential develop-lation of pituitary corticotroph SOCS3 expression: characterization
mental checkpoint in definitive hematopoiesis. Cell 93, 397±409.of the murine SOCS3 promoter. Proc. Natl. Acad. Sci. USA 96, 6964±
6969. Orkin, S.H. (1998). Embryonic stem cells and transgenic mice in the
study of hematopoiesis. Int. J. Dev. Biol. 42, 927±934.Bentley, D., Selfridge, J., Millar, J.K., Samuel, K., Hole, N., Ansell,
J.D., and Melton, D.W. (1996). DNA ligase I is required for fetal liver Orkin, S.H., and Zon, L.I. (1997). Genetics of erythropoiesis: induced
erythropoiesis but is not essential for mammalian cell viability. Nat. mutations in mice and zebrafish. Annu. Rev. Genet. 31, 33±60.
Genet. 13, 489±491. Parganas, E., Wang, D., Stravopodis, D., Topham, D.J., Marine, J.-C.,
Bjorbaek, C., Elmquist, J.K., Frantz, J.D., Shoelson, S.E., and Flier, Teglund, S., Vanin, E.F., Bodner, S., Colamonici, O.R., van Deursen,
J.S. (1998). Identification of SOCS3 as a potential mediator of central J.M., Grosveld, G., and Ihle, J.N. (1998). Jak2 is essential for signaling
leptin resistance. Mol. Cell 1, 619±625. through a variety of cytokine receptors. Cell 93, 385±395.
Bjorbaek, C., Elmquist, J.K., El-Haschimi, K., Kelly, J., Ahima, R.S., Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo,
Hileman, S., and Flier, J.S. (1999). Activation of SOCS3 messenger I., Sasaki, M., Johnston, J.A., and Yoshimura, A. (1999). Cytokine-
ribonucleic acid in the hypothalamus by ciliary neurotrophic factor. inducible SH2 protein-3 (CIS3) inhibits Janus tyrosine kinase by
Endocrinology 140, 2035±2043. binding through the N-terminal kinase inhibitory region as well as
SH2 domain. Genes Cells, in press.Cohney, S.J., Sanden, D., Cacalona, N.A., Yoshimura, A., Mui, A.,
Migone, T.S., and Johnston, J.A. (1999). SOCS3 is tyrosine phos- Socolovsky, M., Fallon, A.E.J., Wang, S., Brugnara, C., and Lodish,
phorylated in response to interleukin-2 and suppresses STAT5 H.F. (1999), Fetal anemia and apoptosis of red cell progenitors in
phosphorylation and lymphocyte proliferation. Mol. Cell. Biol. 19, Stat5a2/25b2/2 mice: a direct role for Stat5 in BclXL induction. Cell
98, 181±191.4980±4988.
SOCS3 Regulates Embryonic Erythropoiesis
627
Song, M.M., and Shuai, K. (1998). The suppressor of cytokine signal-
ing (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibits interferon-
mediated antiviral and antiproliferative activities. J. Biol. Chem. 273,
35056±35062.
Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jen-
kins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A.,
and Hilton, D.J. (1997). A family of cytokine-inducible inhibitors of
signaling. Nature 387, 917±921.
Starr, R., Metcalf, D., Elefanty, A.G., Brysha, M., Willson, T.A., Nicola,
N.A., Hilton, D.J., and Alexander, W.S. (1998). Liver degeneration
and lymphoid deficiencies in mice lacking suppressor of cytokine
signaling-1. Proc. Natl Acad. Sci. USA 95, 14395±14399.
Teglund, S., McKay, C., Schuetz, E., van Deursen, J., Stravopodis,
D., Wang, D., Brown, M., Bodner, S., Grosveld, G., and Ihle, J.N.
(1998). Stat5a and Stat5b proteins have essential and non-essential,
or redundant, roles in cytokine responses. Cell 93, 841±850.
van Deursen, J., Lovell-Badge, R., Oerlemans, F., Schepens, J., and
Wieringa, B. (1991). Modulation of gene activity by consecutive gene
targeting of one creatine kinase M allele in mouse embryonic stem
cells. Nucleic Acids Res. 19, 2637±2643.
van Deursen, J., Heerschap, A., Oerlemans, F., Ruitenbeek, W., Jap,
P., ter Laak, H., and Wieringa, B. (1993). Skeletal muscles of mice
deficient in muscle creatine kinase lack burst activity. Cell 74,
621±631.
Varfolomeev, E.E., Schuchmann, M., Luria, V., Chiannilkulchai, N.,
Beckmann, J.S., Mett, I.L., Rebrikov, D., Brodianski, V.M., Kemper,
O.C., Kollet, O., et al. (1998). Targeted disruption of the mouse
caspase 8 gene ablates cell death induction by the TNF receptors,
Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9, 267±276.
Wu, H., Klingmuller, U., Besmer, P., and Lodish, H.F. (1995a). Interac-
tion of the erythropoietin and stem-cell-factor receptors. Nature 377,
242±246.
Wu, H., Liu, X., Jaenisch, R., and Lodish, H.F. (1995b). Generation
of committed erythroid BFU-E and CFU-E progenitors does not
require erythropoietin or the erythropoietin receptor. Cell 83, 59±67.
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A.,
Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J.N., and
Yoshimura, A. (1999). The JAK-binding protein JAB inhibits Janus
tyrosine kinase activity through binding in the activation loop. EMBO
J. 18, 1309±1320.
Yeh, W.-C., de la Pompa, J.L., McCurrach, M.E., Shu, H., Elia, A.J.,
Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al.
(1998). FADD: essential for embryo development and signaling from
some, but not all, inducers of apoptosis. Science 279, 1954±1958.
Yoshimura, A., Ohkubo, T., Kiguchi, T., Jenkins, N.A., Gilbert, D.J.,
Copeland, N.G., Hara, T., and Miyajima, A. (1995). A novel cytokine-
inducible gene CIS encodes an SH2-containing protein that binds to
tyrosine-phosphorylated interleukin-3 and erythropoietin receptors.
EMBO J. 14, 2816±2826.
Zhang, J.G., Farley, A., Nicholson, S.E., Willson, T.A., Zugaro, L.M.,
Simpson, R.J., Moritz, R.L., Cary, D., Richardson, R., Hausmann,
G., et al. (1999). The conserved SOCS box motif in suppressors of
cytokine signaling binds to elongins B and C and may couple bound
proteins to proteasomal degradation. Proc. Natl Acad. Sci. USA 96,
2071±2076.
